Panacea Biotec releases Q2 2025 unaudited financial results

Panacea Biotec has published an extract of its unaudited standalone and consolidated financial results for the quarter and half-year ended September 30, 2025. These results were published in Business Standard (English) and Desh Sewak (Punjabi) newspapers on November 15, 2025, in compliance with Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The announcement was made by Vinod Goel, group cfo and head legal & company secretary, on behalf of Panacea Biotec Limited. The company’s registered office is in Lalru, Punjab, with its corporate office located in New Delhi, India.

This disclosure follows the letter dated November 14, 2025, which sought approval for these provisional results. The company has fulfilled its regulatory obligations by disseminating the unaudited financial statements to the public.